Engineering of nano-crystalline drug suspensions: Employing a physico-chemistry based stabilizer selection methodology or approach - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue International Journal of Pharmaceutics Année : 2014

Engineering of nano-crystalline drug suspensions: Employing a physico-chemistry based stabilizer selection methodology or approach

Résumé

This paper describes a systematic approach to select optimum stabilizer for the preparation of nano-crystalline suspensions of an active pharmaceutical ingredient (API). The stabilizer can be either a dispersant or a combination of dispersant and wetting agent. The proposed screening method is a quick and efficient way to investigate a large number of stabilizers based on the principles of physical-chemistry and employs a stepwise approach. The methodology has been divided in two main parts; the first part being focused on the qualitative screening with the objective of selecting the best candidate(s) for further investigation, the second part has been focused on quantitative screening with the objective to optimize the ratio and amount of wetting and dispersing agents, based on wettability, surface charges measurement, adsorption evaluation, process-ability evaluation and storage stability. The results showed clearly that SDS/PVP 40/60% (w/w) (sodium dodecyl sulfate/poly(vinyl pyrrolidone)) at a total concentration of 1.2% was the optimum stabilizer composition, at which the resulting nanosuspensions were stable for more than 50 days at room temperature.
Fichier principal
Vignette du fichier
engineering-of-nano-crystalline-drug-suspensions.pdf (2.28 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01593328 , version 1 (08-11-2018)

Identifiants

Citer

Jean-Rene Authelin, Mostafa Nakach, Jean-René Authelin, Tharwat Tadros, Laurence Galet, et al.. Engineering of nano-crystalline drug suspensions: Employing a physico-chemistry based stabilizer selection methodology or approach. International Journal of Pharmaceutics, 2014, 476 (1-2), p. 277-288. ⟨10.1016/j.ijpharm.2014.09.048⟩. ⟨hal-01593328⟩
82 Consultations
416 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More